Parsippany-based Teva Pharmaceuticals USA Inc. has expanded its voluntary consumer-level recall originally initiated on April 25, 2019 in the United States of losartan potassium tablets. In a press ...
Vivimed Life Sciences has issued a voluntary recall of its losartan potassium tablets after the impurity N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) was detected. It’s used to treat high blood ...
Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral suspension ...
Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. In a Sept. 19 statement, ...
NEW YORK (CBSNewYork) – Another blood pressure medication has been added to the massive recall – linking the drugs to cancer-causing chemicals. The FDA announced on Thursday that Torrent ...
Another 19 lots of losartan tablets, these made by Vivimed Life Sciences and distributed by Heritage Pharmaceuticals, have been recalled for exceeding the FDA allowable amount of NMBA. “Based on the ...
The Food and Drug Administration is again expanding its recall of widely prescribed blood pressure drugs due to contamination with a cancer-linked chemical. Monday's announcement targets an additional ...
Expanded Coverage Reaches Over 100 Million Covered Lives Nationwide COMMACK, NY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC.
Sept. 24 (UPI) --The U.S. Food and Drug administration has expanded a recall for generic blood pressure medications due to possible contamination with a cancer-causing chemical, regulators said. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback